Oxy Deep Pore Acne Cleansing Pads

Description

The product is identified by the SPL code 34089-3. No additional specific description details are available.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears acne pimples and facilitates the healing of the skin. The formulation penetrates pores to control the formation of blackheads and whiteheads, while also helping to prevent the emergence of new acne pimples.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals are advised to initiate treatment by thoroughly cleaning the affected skin area with a wipe. A thin layer of the medication should be applied to the entire affected area one to three times daily, depending on the patient's needs and the physician's recommendations.

It is recommended to start with one application per day to minimize the risk of excessive drying of the skin. If tolerated, the frequency of application may be gradually increased to two or three times daily. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day to alleviate these symptoms.

Contraindications

The product is contraindicated in patients who may leave the pad on the skin for extended periods. Prolonged contact with the skin may lead to irritation or other adverse effects. No other contraindications have been identified.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, lips, and mouth. In the event of accidental contact, the affected area should be flushed thoroughly with water to mitigate any potential irritation.

General precautions should be observed to minimize the risk of skin irritation and dryness. The concurrent use of this product with other topical acne medications may increase the likelihood of adverse skin reactions. Therefore, it is recommended to use only one topical acne medication at a time to prevent irritation.

The product should not be left on the skin for extended periods. Adherence to the recommended usage guidelines is essential for safe application.

In case of ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients should be advised that the product is for external use only. This warning is critical to ensure safe and appropriate use, minimizing the risk of adverse reactions associated with improper application.

No specific adverse reactions have been reported in clinical trials or postmarketing experiences. However, as with any topical product, patients may experience localized reactions such as irritation, redness, or allergic responses. It is essential for patients to monitor for any unexpected symptoms and consult a healthcare professional if they occur.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Oxy Deep Pore Acne Cleansing Pads (salicylic acid 2%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily. Depending on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily. Care should be taken to observe for excessive drying of the skin; if bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of Oxy Deep Pore Acne Cleansing Pads in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, the following management procedures should be considered:

1. Assessment: Conduct a thorough assessment of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide supportive care as needed, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Consultation: Engage with a poison control center or a medical toxicologist for guidance on specific interventions and antidotes, if applicable.

4. Documentation: Document all findings, interventions, and the patient's response to treatment meticulously.

Healthcare professionals should remain vigilant and prepared to implement appropriate measures in the event of an overdose, even in the absence of specific guidelines.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to emphasize the need to keep the product away from the eyes, lips, and mouth. In the event of contact with these areas, patients should be instructed to flush thoroughly with water.

Providers should also inform patients that using this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. If patients experience irritation, they should be counseled to limit their use to one topical acne medication at a time to minimize adverse effects.

Additionally, patients should be cautioned not to leave the pad on the skin for extended periods, as this may lead to unwanted skin reactions. Clear communication of these points will help ensure safe and effective use of the product.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored in a cool, dry place, away from moisture and heat sources. Freezing the product is not recommended, as it may compromise its quality. After opening, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is also important to keep the product out of reach of children; if ingested, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Oxy Deep Pore Acne Cleansing Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)